Literature DB >> 20024083

The influence of EDTA and citrate anticoagulant addition to human plasma on information recovery from NMR-based metabolic profiling studies.

Richard H Barton1, Daniel Waterman, Frank W Bonner, Elaine Holmes, Robert Clarke, Jeremy K Nicholson, John C Lindon.   

Abstract

The widely-used blood anticoagulants citrate and EDTA give rise to prominent peaks in (1)H NMR spectra of plasma samples collected in epidemiological and clinical studies, and these cause varying levels of interference in recovering biochemical information on endogenous metabolites. To investigate both the potential metabolic information loss caused by these substances and any possible inter-molecular interactions between the anticoagulants and endogenous components, the (1)H NMR spectra of 40 split human plasma samples collected from 20 individuals into either citrate or EDTA have been analysed. Endogenous metabolite peaks were selectively obscured by large citrate peaks or those from free EDTA and its calcium and magnesium complexes. It is shown that the endogenous metabolites that give rise to peaks obscured by those from EDTA or citrate almost invariably also have other resonances that allow their identification and potential quantitation. Also, metabolic information recovery could be maximised by use of spectral editing techniques such as spin-echo, diffusion-editing and J-resolved experiments. The NMR spectral effects of any interactions between the added citrate or EDTA and endogenous components were found to be negligible. Finally, identification of split samples was feasible using simple multivariate statistical approaches such as principal components analysis. Thus even when legacy epidemiological plasma samples have been collected using the NMR-inappropriate citrate or EDTA anticoagulants, useful biochemical information can still be recovered effectively.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20024083     DOI: 10.1039/b907021d

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  19 in total

1.  The Plasma and Serum Metabotyping of Hepatocellular Carcinoma in a Nigerian and Egyptian Cohort using Proton Nuclear Magnetic Resonance Spectroscopy.

Authors:  Mohamed I F Shariff; Jin Un Kim; Nimzing G Ladep; Asmaa I Gomaa; Mary M E Crossey; Edith Okeke; Edmund Banwat; Imam Waked; I Jane Cox; Roger Williams; Elaine Holmes; Simon D Taylor-Robinson
Journal:  J Clin Exp Hepatol       Date:  2017-03-15

Review 2.  Understanding preanalytical variables and their effects on clinical biomarkers of oncology and immunotherapy.

Authors:  Lokesh Agrawal; Kelly B Engel; Sarah R Greytak; Helen M Moore
Journal:  Semin Cancer Biol       Date:  2017-12-16       Impact factor: 15.707

3.  1H nuclear magnetic resonance-based extracellular metabolomic analysis of multidrug resistant Tca8113 oral squamous carcinoma cells.

Authors:  Hui Wang; Jiao Chen; Yun Feng; Wenjie Zhou; Jihua Zhang; Y U Yu; Xiaoqian Wang; Ping Zhang
Journal:  Oncol Lett       Date:  2015-04-21       Impact factor: 2.967

4.  Metabolomics reveals increased isoleukotoxin diol (12,13-DHOME) in human plasma after acute Intralipid infusion.

Authors:  Lindsay M Edwards; Nathan G Lawler; Sonja B Nikolic; James M Peters; James Horne; Richard Wilson; Noel W Davies; James E Sharman
Journal:  J Lipid Res       Date:  2012-06-19       Impact factor: 5.922

Review 5.  Role of hypertension in kidney transplant recipients.

Authors:  Charalampos Loutradis; Pantelis Sarafidis; Smaragdi Marinaki; Miriam Berry; Richard Borrows; Adnan Sharif; Charles J Ferro
Journal:  J Hum Hypertens       Date:  2021-05-04       Impact factor: 3.012

6.  Metabolomic profile of umbilical cord blood plasma from early and late intrauterine growth restricted (IUGR) neonates with and without signs of brain vasodilation.

Authors:  Magdalena Sanz-Cortés; Rodrigo J Carbajo; Fatima Crispi; Francesc Figueras; Antonio Pineda-Lucena; Eduard Gratacós
Journal:  PLoS One       Date:  2013-12-02       Impact factor: 3.240

Review 7.  The emergence of proton nuclear magnetic resonance metabolomics in the cardiovascular arena as viewed from a clinical perspective.

Authors:  Naomi J Rankin; David Preiss; Paul Welsh; Karl E V Burgess; Scott M Nelson; Debbie A Lawlor; Naveed Sattar
Journal:  Atherosclerosis       Date:  2014-09-30       Impact factor: 5.162

8.  Metabolomic analysis reveals extended metabolic consequences of marginal vitamin B-6 deficiency in healthy human subjects.

Authors:  Jesse F Gregory; Youngja Park; Yvonne Lamers; Nirmalya Bandyopadhyay; Yueh-Yun Chi; Kichen Lee; Steven Kim; Vanessa da Silva; Nikolas Hove; Sanjay Ranka; Tamer Kahveci; Keith E Muller; Robert D Stevens; Christopher B Newgard; Peter W Stacpoole; Dean P Jones
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

9.  Discovery of Infection Associated Metabolic Markers in Human African Trypanosomiasis.

Authors:  Sabrina D Lamour; Maria Gomez-Romero; Panagiotis A Vorkas; Vincent P Alibu; Jasmina Saric; Elaine Holmes; Jeremy M Sternberg
Journal:  PLoS Negl Trop Dis       Date:  2015-10-27

10.  1H-NMR metabolomic biomarkers of poor outcome after hemorrhagic shock are absent in hibernators.

Authors:  Lori K Bogren; Carl J Murphy; Erin L Johnston; Neeraj Sinha; Natalie J Serkova; Kelly L Drew
Journal:  PLoS One       Date:  2014-09-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.